A new study found that differences between a person s age in years and his or her biological age, as predicted by an artificial intelligence (AI)-enabled EKG, can provide measurable insights into health and longevity, according to Mayo Clinic.
E-Mail
ROCHESTER, Minn. You might be older - or younger - than you think. A new study found that differences between a person s age in years and his or her biological age, as predicted by an artificial intelligence (AI)-enabled EKG, can provide measurable insights into health and longevity.
The AI model accurately predicted the age of most subjects, with a mean age gap of 0.88 years between EKG age and actual age. However, a number of subjects had a gap that was much larger, either seemingly much older or much younger by EKG age.
The likelihood to die during follow-up was much higher among those seemingly older by EKG age, compared to those whose EKG age was the same as their chronologic or actual age. The association was even stronger when predicting death caused by heart disease. Conversely, those who had a lesser age gap ? considered younger by EKG - had decreased risk.
You might be older ― or younger ― than you think. A new study found that differences between a person's age in years and his or her biological age, as.
email article
The FDA accepted a new drug application for BioXcel Therapeutics novel, orally dissolving thin film formulation of dexmedetomidine BXCL501 for the acute treatment of agitation associated with schizophrenia and bipolar disorders I and II, based on the phase III SERENITY trials presented at this year s American Psychiatric Association meeting.
Many state medical board license applications do not follow national recommendations aimed at protecting physicians mental health as only one state, North Carolina, has fully adopted the Federation of State Medical Boards recommendations. (
JAMA)
The FDA gave the green light to PharmaTher Holdings to evaluate ketamine in the treatment of levodopa-induced dyskinesia in patients with Parkinson s disease in a phase II trial.